38 results on '"Clerici, D."'
Search Results
2. Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease
3. Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide
4. Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies
5. Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation
6. Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients
7. Post-transplantation cyclophosphamide is associated with increased bacterial infections
8. Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir
9. Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis
10. Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party
11. Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review
12. Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
13. Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients
14. Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality
15. Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching
16. HLA-haplotype loss after TCRαβ/CD19-depleted haploidentical HSCT
17. Are we ready for post-transplant cyclophosphamide use in matched donor transplants?
18. Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting
19. Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?
20. Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
21. Halfway there: the past, present and future of haploidentical transplantation
22. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
23. FOXP3+ regulatory T cells and their functional regulation
24. A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia
25. Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation
26. Author Index
27. Author Index
28. Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall
29. Author Index
30. Long-term follow-up of a pilot study using a chemotherapy-alone protocol for killer Ig-like receptor-ligand-mismatched haploidentical haematopoietic SCT
31. Author Index
32. Author Index
33. Author Index
34. Author Index
35. Abstracts of the Nurses Group
36. Physicians Poster Abstracts
37. Author Index
38. Haploidentical transplantation in patients with acquired aplastic anemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.